Proqr Therapeutics NVPRQR
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 48 institutions reported holding Proqr Therapeutics NV (PRQR) in their 13F filings, down 1 from Q1 2024. 3 opened new positions and 3 sold out. The largest holders were Privium Fund Management B.V. ($9.2M), Adage Capital Partners Gp, L.L.C. ($6.0M) and EcoR1 Capital, LLC ($3.4M). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Proqr Therapeutics NV
- CUSIP
- N71542109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $1.6M |
| Exits | 3 | $109K |
All 13F filers, Q1 2024 → Q2 2024: 1,249,282 shares bought and 1,341,815 shares sold, net −92,533 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 48 holders
| Privium Fund Management B.V. | 2.57% | Add +4.4% | 5,580,725 | $9.2M |
| Adage Capital Partners Gp, L.L.C. | 0.01% | No change | 3,625,467 | $6.0M |
| EcoR1 Capital, LLC | 0.10% | Reduce -29.2% | 2,042,771 | $3.4M |
| M28 Capital Management LP | 2.19% | No change | 1,019,498 | $1.7M |
| DAFNA Capital Management LLC | 0.36% | No change | 905,582 | $1.5M |
| Ghost Tree Capital, LLC | 0.52% | New | 900,000 | $1.5M |
| Macquarie Group Ltd. | 0.00% | No change | 620,000 | $1.0M |
| Ikarian Capital, LLC | 0.25% | No change | 483,583 | $803K |
| Deutsche Bank AG | 0.00% | No change | 385,149 | $639K |
| Monaco Asset Management SAM | 0.26% | No change | 312,629 | $519K |
| Franklin Street Advisors Inc. | 0.02% | No change | 150,000 | $249K |
| Millennium Management | 0.00% | Reduce -54.9% | 148,357 | $246K |
| Two Sigma Advisers, LP | 0.00% | Reduce -18.8% | 131,500 | $218K |
| Boothbay Fund Management, LLC | 0.01% | No change | 106,703 | $177K |
| Susquehanna International Group, LLP | 0.00% | Reduce -31.4% | 96,118 | $160K |
| Squarepoint Ops LLC | 0.00% | Reduce -44.4% | 84,733 | $141K |
| Morgan Stanley | 0.00% | Add +15.3% | 77,942 | $129K |
| Bank of America Corp. | 0.00% | Reduce -33.5% | 73,163 | $121K |
| Two Sigma Investments, LP | 0.00% | Reduce -12.7% | 68,945 | $114K |
| Schonfeld Strategic Advisors LLC | 0.00% | New | 61,900 | $103K |
| BNP Paribas Financial Markets | 0.00% | Add +47.1% | 51,501 | $85K |
| Geode Capital Management, LLC | 0.00% | No change | 46,671 | $77K |
| OneDigital Investment Advisors LLC | 0.00% | Reduce -6.7% | 42,000 | $70K |
| Bank of Montreal | 0.00% | No change | 30,000 | $53K |
| RFG Advisory, LLC | 0.00% | No change | 32,000 | $53K |
| UBS Group AG | 0.00% | Add +454.3% | 27,546 | $46K |
| Vanguard Personalized Indexing Management, LLC | 0.00% | No change | 21,429 | $36K |
| Citadel Advisors | 0.00% | Reduce -60.1% | 18,365 | $30K |
| Mariner, LLC | 0.00% | No change | 18,334 | $30K |
| Northern Trust Corp. | 0.00% | Reduce -8.5% | 15,932 | $26K |
| Atom Investors LP | 0.00% | No change | 13,107 | $22K |
| Two Sigma Securities, LLC | 0.00% | Reduce -47.5% | 12,471 | $21K |
| Osaic Holdings, Inc. | 0.00% | Reduce -4.4% | 12,250 | $20K |
| EP Wealth Advisors, LLC | 0.00% | No change | 11,500 | $19K |
| Wells Fargo & Company | 0.00% | No change | 10,996 | $18K |
| Csenge Advisory Group | 0.00% | No change | 10,000 | $17K |
| Kestra Advisory Services, LLC | 0.00% | No change | 10,000 | $17K |
| Truist Financial Corp. | 0.00% | No change | 10,000 | $17K |
| Simplex Trading, LLC | 0.00% | Reduce -51.1% | 6,628 | $11K |
| Group One Trading LLC | 0.00% | Reduce -57.8% | 4,090 | $7K |
| BlackRock Inc. | 0.00% | No change | 3,945 | $7K |
| Acadian Asset Management LLC | 0.00% | Reduce -84.1% | 3,933 | $6K |
| Royal Bank of Canada | 0.00% | Add +427.5% | 1,055 | $2K |
| PFS Partners, LLC | 0.00% | No change | 1,000 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 821 | $1K |
| JPMorgan Chase & Co. | 0.00% | Reduce -79.0% | 314 | $521 |
| Qube Research & Technologies Ltd | 0.00% | No change | 33 | $55 |
| Lazard Asset Management LLC | 0.00% | Reduce -93.3% | 276 | $0 |
"% of holder's portfolio" is PRQR's weight in each manager's 13F, not the share of Proqr Therapeutics NV the manager owns.